ó㳺 ISSN: 2707-0441 eISSN: 2707-045X
69, 2019   -   : 261-269
ͳ ..1, ..1, ..1
1 " ' . .. Ǫ "

: 615.074
https://doi.org/10.32402/hygiene2019.69.261

ֲ:
: ί Բֲί ֲ̲ Ҳ ˲ Ҳ .
: .
' . , - .
. , , , 䳿.
, , (), , - (). , -, ' , .
, 䳺 -, - (), -.
.
, , - (), , 2 4 .
. . , , / . . .

² :
, , , , , , .

˲:
1. Lobenberg R., Amidon G.L. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. European Journal of Pharmaceutics and Biopharmaceutics. 2000. Vol. 50 (1). P. 3-12.
2. General Notes on Biopharmaceutics Classification System (BCS)-based Biowaiver Applications. WHO Guidance Document (22 March 2019). URL : https://extranet.who.int/prequal/sites/default/files/documents/35%20Biowaiver%20general_March2019.pdf.
3. Yohey Kawabata, Koichi Wada, Manabu Nakatani, ShizuoYamada, Satomi Onoue. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. International Journal of Pharmaceutics. 2011. Vol. 420 (1). P. 1 10. DOI : https://doi.org/10.1016/j.ijpharm.2011.08.032
4. Solubility, Delivery and ADME Problems of Drugs and Drug Candidates. Edited by K. Tihanyi and M. Vastag. Bentam e-books, 2018. 232 p. DOI : https://doi.org/10.2174/97816080512051110101
5. Avdeef A. Absorbtion and Drug Development, Second Edition. John Wiley & Sons, Inc. : 2012. 698 p. DOI : https://doi.org/10.1002/9781118286067
6. Biopharmaceutical Classification System and Formulation Development. Technical Brief. 2011. Vol. 9. URL : https://www.particlesciences.com/docs/technical_briefs/TB_2011_9.pdf
7. Biopharmaceutics Classification System-based Biowaivers. M9 ICH Consensus Guideline. URL : https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/ M9/M9EWG_DraftGuideline_Step2_2018_0606.pdf
10. Rana A., Kumar S. Manufacturing Defects of Tablets A Review. Journal of Drug Delivery & Therapeutics. 2013. Vol. 3(6). P. 200-206. DOI : https://doi.org/10.22270/jddt.v3i6.722
11. Pharmaceutical Dosage Forms: TABLETS, Third Edition. Volume 1: Unit Operations and Me-chanical Properties. Ed. by Augsburger L.L. & Hoag S.W. Informa Healthcare USA, Inc, 2008. 311 p. DOI : https://doi.org/10.3109/9781420020281
12. Singh S., Rama Rao K.V., Venugopal K., Manikandan R. Alteration in Dissolution Characteristics of Gelatin-Containing Formulations. A Review of the Problem, Test Methods, and Solutions. Pharmaceutical Technology. 2002. April. P. 36-58.
14. United State Pharmacopoeia & National Formulary. URL : https://www.uspnf.com
15. European Pharmacopoeia (Ph. Eur.). URL : https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-9th-edition
16. British Pharmacopoeia. URL : https://www.pharmacopoeia.com
18. Kappelle W.F., Siersema P.D., Bogte A., Vleggaar F.P. Challenges in oral drug delivery in patients with esophageal dysphagia. Expert Opinion on Drug Delivery. 2016. Vol. 13(5). P. 645-658. DOI : https://doi.org/10.1517/17425247.2016.1142971
19. Mounica P., Pavani S., Mounica Rani P. A review on recent advances in enteric coating and enteric polymers. World Journal of Pharmaceutical Research. 2018. Vol. 7, Iss. 2. P. 475-495. DOI: https://doi.org/10.20959/wjpr20182-10795
20. Nimesulide Actions and Uses. Ed. by Rainsford K.D. Basel : Birkhauser Verlag, 2005. 433 p. DOI : https://doi.org/10.1007/3-7643-7410-1

:
.., .., .. . ó㳺 : . . . ., 2019. . 69. . 261-269.